Literature DB >> 20634363

The effects of hypertension and body mass index on cognition in schizophrenia.

Joseph I Friedman1, Sylvan Wallenstein, Erin Moshier, Michael Parrella, Leonard White, Stephanie Bowler, Stephanie Gottlieb, Philip D Harvey, Thomas G McGinn, Lauren Flanagan, Kenneth L Davis.   

Abstract

OBJECTIVE: In recent years there has been a greater appreciation of the elevated prevalence of cardiovascular risk factors in the schizophrenia population and the liability some treatments have for their development. These vascular risk factors are in turn important risk factors in the development of dementia and more subtle cognitive impairments. However, their impact on the cognitive functions of patients with schizophrenia remains underexplored. The authors investigated whether vascular risk factors influence the cognitive impairments of schizophrenia and whether their effects on cognition in schizophrenia are different from those observed in nonpsychiatric comparison subjects.
METHOD: The authors compared 100 patients with schizophrenia and 53 comparison subjects on cognitive test performance in 2×2 matrices composed of individual vascular risk factors and group (schizophrenia patients and comparison subjects).
RESULTS: Hypertension exerted a significant negative effect on immediate delayed and recognition memory in both groups. Patients with schizophrenia and hypertension were adversely affected in recognition memory, whereas comparison subjects were not. A body mass index above 25 was associated with negative effects on delayed memory in both groups, although the association fell short of statistical significance.
CONCLUSIONS: Given that patients with schizophrenia have a higher prevalence of vascular risk factors than the general population and are undertreated for them, treatment of these risk factors may significantly improve cognitive outcome in schizophrenia.

Entities:  

Mesh:

Year:  2010        PMID: 20634363     DOI: 10.1176/appi.ajp.2010.09091328

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  28 in total

1.  Endothelial function, folate pharmacogenomics, and neurocognition in psychotic disorders.

Authors:  Tyler Grove; Stephan Taylor; Gregory Dalack; Vicki Ellingrod
Journal:  Schizophr Res       Date:  2015-02-23       Impact factor: 4.939

2.  Is Metabolic Syndrome On the Radar? Improving Real-Time Detection of Metabolic Syndrome and Physician Response by Computerized Scan of the Electronic Medical Record.

Authors:  Kingwai Lui; Gagandeep Randhawa; Vicken Totten; Adam E Smith; Joachim Raese
Journal:  Prim Care Companion CNS Disord       Date:  2016-01-28

3.  A 52-week, double-blind evaluation of the metabolic effects of aripiprazole and lithium in bipolar I disorder.

Authors:  Roger S McIntyre; Susan L McElroy; James M Eudicone; Robert A Forbes; Berit X Carlson; Ross A Baker
Journal:  Prim Care Companion CNS Disord       Date:  2011

4.  Aerobic Exercise in People with Schizophrenia: Neural and Neurocognitive Benefits.

Authors:  Julia Vakhrusheva; Brielle Marino; T Scott Stroup; David Kimhy
Journal:  Curr Behav Neurosci Rep       Date:  2016-04-04

5.  Health status and mobility limitations are associated with residential and employment status in schizophrenia and bipolar disorder.

Authors:  M Strassnig; D Cornacchio; P D Harvey; R Kotov; L Fochtmann; E J Bromet
Journal:  J Psychiatr Res       Date:  2017-07-18       Impact factor: 4.791

6.  Relationship between changes in metabolic syndrome constituent components over 12 months of treatment and cognitive performance in first-episode schizophrenia.

Authors:  H K Luckhoff; S Kilian; M R Olivier; L Phahladira; F Scheffler; S du Plessis; B Chiliza; L Asmal; R Emsley
Journal:  Metab Brain Dis       Date:  2019-01-02       Impact factor: 3.584

7.  Diabetes is associated with lower global cognitive function in schizophrenia.

Authors:  Yoichiro Takayanagi; Nicola G Cascella; Akira Sawa; William W Eaton
Journal:  Schizophr Res       Date:  2012-09-29       Impact factor: 4.939

Review 8.  Associations between health risk behaviors and symptoms of schizophrenia and bipolar disorder: a systematic review.

Authors:  Joseph M Cerimele; Wayne J Katon
Journal:  Gen Hosp Psychiatry       Date:  2012-10-06       Impact factor: 3.238

9.  Aerobic fitness and body mass index in individuals with schizophrenia: Implications for neurocognition and daily functioning.

Authors:  David Kimhy; Julia Vakhrusheva; Matthew N Bartels; Hilary F Armstrong; Jacob S Ballon; Samira Khan; Rachel W Chang; Marie C Hansen; Lindsey Ayanruoh; Edward E Smith; Richard P Sloan
Journal:  Psychiatry Res       Date:  2014-09-03       Impact factor: 3.222

10.  Association of obesity and treated hypertension and diabetes with cognitive ability in bipolar disorder and schizophrenia.

Authors:  Colin A Depp; Martin Strassnig; Brent T Mausbach; Christopher R Bowie; Paula Wolyniec; Mary H Thornquist; James R Luke; John A McGrath; Ann E Pulver; Thomas L Patterson; Philip D Harvey
Journal:  Bipolar Disord       Date:  2014-04-12       Impact factor: 6.744

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.